Department of Digestive Diseases, Virgen de la Victoria University Hospital, Málaga, Spain.
Department of Digestive Diseases, Virgen Macarena University Hospital, Seville, Spain.
Int J Colorectal Dis. 2019 Jul;34(7):1241-1250. doi: 10.1007/s00384-019-03318-x. Epub 2019 May 25.
Stenting as a bridge to surgery (SBTS) can transform an emergency surgery (ES) into an elective surgery in patients with symptomatic left-sided malignant colonic obstruction. Concerns have been raised regarding short-term morbidity and long-term oncologic outcomes, with contrasting results reported in the literature. Our main aim is to evaluate not only long-term oncologic outcomes but also short-term postoperative outcomes of stented patients who underwent elective surgery compared to those who had ES.
From January 2006 to May 2012, we retrospectively identified patients with confirmed left-sided colorectal cancer obstruction. This was done in two centers of reference of colorectal diseases in southern Spain with patients who were treated with curative intent either with ES or SBTS. The short- and long-term results were compared between both groups.
There were 71 patients in the stenting group and 66 in the emergency surgery group, with similar demographic data. Initial stoma creation rates were lower in the SBTS group (16.9% vs. 54.5%, p < 0.005) and the primary anastomosis rate was higher in the same group (83.1% vs. 45.5%, p < 0.005). Five-year recurrence-free survival (RFS) rates were comparable between groups (75.3 vs. 59.8%, p = 0.220), but RFS rates at 5 years for AJCC pathologic stage III were higher in the stenting group (69.7% vs 30%, p = 0.004). Both groups were comparable regarding overall and cancer-specific survival outcomes.
The use of SBTS reduces ostomy rates in patients with obstructive colon malignancies. Long-term survival results are similar. Patients in the SBTS group with stage III AJCC status showed a higher 5-year recurrence-free survival rate than those in the ES group.
对于有症状的左侧恶性结直肠梗阻患者,支架置入作为桥接手术(SBTS)可以将急诊手术(ES)转化为择期手术。人们对短期发病率和长期肿瘤学结果表示担忧,文献中报告的结果存在差异。我们的主要目的不仅是评估接受择期手术的支架置入患者的长期肿瘤学结果,而且还评估与接受 ES 治疗的患者相比,他们的短期术后结果。
从 2006 年 1 月至 2012 年 5 月,我们回顾性地确定了患有确诊左侧结直肠癌梗阻的患者。这项工作在西班牙南部的两个结直肠疾病参考中心进行,患者接受了根治性治疗,要么接受 ES,要么接受 SBTS。比较了两组之间的短期和长期结果。
支架组有 71 例患者,急诊手术组有 66 例患者,两组患者的人口统计学数据相似。SBTS 组的初始造口创建率较低(16.9%比 54.5%,p<0.005),而同一组的初次吻合率较高(83.1%比 45.5%,p<0.005)。两组的 5 年无复发生存率(RFS)相当(75.3%比 59.8%,p=0.220),但 SBTS 组 AJCC 病理分期 III 期的 RFS 率更高(69.7%比 30%,p=0.004)。两组在总体和癌症特异性生存结果方面相当。
SBTS 的使用降低了梗阻性结肠恶性肿瘤患者的造口率。长期生存结果相似。SBTS 组中 AJCC 分期为 III 期的患者 5 年无复发生存率高于 ES 组。